Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.26B Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 4.42% Avg Daily Range (30 D): $0.08 | 3.43% Avg Daily Range (90 D): $0.06 | 2.60% Institutional Daily Volume Avg Daily Volume: 3.76M Avg Daily Volume (30 D): 9.47M Avg Daily Volume (90 D): 8.86M Trade Size Avg Trade Size (Sh.): 226 Avg Trade Size (Sh.) (30 D): 396 Avg Trade Size (Sh.) (90 D): 416 Institutional Trades Total Inst.Trades: 1,257 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $.9M Avg Inst. Trade (90 D): $1.85M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.88M Avg Closing Trade (30 D): $.94M Avg Closing Trade (90 D): $1.43M Avg Closing Volume: 372.73K     News Nov 25, 2025 @ 2:00 PM Q3 2025 Contract Research Organization (CRO) Activ... Source: Researchandmarkets.Com Nov 19, 2025 @ 5:29 PM A Fresh $16 Million Bet on ImmunityBio: What Inves... Source: Adam Palasciano Nov 19, 2025 @ 5:09 PM Heights Capital Walks From Archer Aviation: What I... Source: Adam Palasciano Nov 19, 2025 @ 5:08 PM Heights Capital Just Ditched Its $12.5 Million AMS... Source: Adam Palasciano Oct 22, 2025 @ 5:42 PM Looking For The Next Beyond Meat? Here Are The Top... Source: Erica Kollmann Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.07 $-.1 $-.15 Diluted EPS $-.07 $-.1 $-.15 Revenue $ 32.06M $ 26.43M $ 16.52M Gross Profit $ 31.88M $ 26.29M $ 16.46M Net Income / Loss $ -67.27M $ -92.57M $ -129.67M Operating Income / Loss $ -55.63M $ -71.29M $ -64.43M Cost of Revenue $ .18M $ .14M $ .06M Net Cash Flow $ -76.75M $ 76.92M $ -82.76M PE Ratio